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ABSTRACT
Poly(A) polymerase (PAP), which adds poly(A)
tails to the 3’ end of mRNA, can be phosphorylated
at several sites in the C-terminal domain.
Phosphorylation often mediates regulation by extra-
cellular stimuli, suggesting PAP may be regulated by
such stimuli. In this study, we found that phosphor-
ylation of PAP was increased upon growth stimula-
tion and that the mitogen-activated protein kinase
ERK was responsible for the increase in phosphor-
ylation. We identified serine 537 of PAP as a unique
phosphorylation site by ERK. PAP phosphorylation
of serine 537 by ERK increased its nonspecific
polyadenylation activity in vitro. This PAP activity
was also activated by stimulation of ERK with
phorbol-12-myristate-13-acetate in vivo. These
data suggest that ERK is a novel regulatory kinase
for PAP and further, that PAP activity could be
regulated by extracellular stimuli through an ERK-
dependent signaling pathway(s).
INTRODUCTION
Primary mRNA transcripts are processed to their mature
forms by a series of coordinated events in the nucleus
including capping, splicing, cleavage and poly(A) addition.
Cleavage and poly(A) addition at the 30 end of the mRNA
marks the end of mRNA synthesis. Cleavage takes place
between the upstream hexamer (AAUAAA) (1,2) and the
downstream GU rich sequences (3), and a poly(A) tail
of 200–250 residues in length is then synthesized at the
cleavage site by the 30 end formation machinery. The 30end
formation machinery is composed of multiple transacting
factors,includingcleavage-andpolyadenylation-speciﬁcity
factor (CPSF), cleavage-stimulation factor (CstF), two
cleavage factors (CFI and CFII), poly(A) polymerase
(PAP) and poly(A)-binding protein II (4–8). PAP is the
enzyme responsible for the synthesis of the poly(A) tails.
In addition to nuclear polyadenylation, polyadenylation
of mRNA can also occur in the cytoplasm. Additional
cis-elements such as cytoplasmic polyadenylation element
(CPE) and adenylation control element (ACE) (9–11),
and other transacting factors such as CPSF and cyto-
plasmic polyadenylation element binding protein (CPEB)
(12) are involved in cytoplasmic polyadenylation.
Because the poly(A) tail plays essential roles in mRNA
stability, transport and translation (13,14), polyadenyla-
tion may be an important regulatory step in diverse
cellular processes (15–17) and PAP is a likely target
for regulation. The catalytic domain of PAP is in the
N-terminus (18,19). The C-terminal region carries an
RNA-binding domain, two nuclear localization signals
and a serine/threonine-rich regulatory domain (20), and
also serves as a platform for regulatory proteins whose
binding modulates the activity or cellular localization of
PAP (21–23).
Activity of PAP could also be controlled through
phosphorylation of the C-terminal domain (CTD). The
serine/threonine-rich region in CTD contains multiple
cyclin-dependent kinase (cdk) sites, which are phosphory-
lated in vitro and in vivo by p34cdc2/cyclin B (24).
Growing evidence suggests that PAP can be regulated
during several phases of the cell cycle. In M-phase, PAP
is hyperphosphorylated by p34cdc2/cyclin B and the
hyperphosphorylated PAP shows reduced activity
in vitro. Increased polyadenylation activity has been
reported during the G0 to S phase transition (25,26).
Furthermore, PAP can be phosphorylated by G1 and G2
type cyclin-dependent kinases and interacts with both G1
and G2 type cyclins (27). However, the biological
relevance of phosphorylation of PAP and the speciﬁcity
of the phosphorylation sites during the cell cycles remain
unclear. Importantly, despite extracellular stimuli usually
trigger protein phosphorylation in the cell, regulation of
PAP by extracellular stimuli has not been examined.
The present study was designed to determine, ﬁrst, how
phosphorylation of PAP changes upon growth stimulation
and, second, which kinase is responsible for phosphoryla-
tion of PAP and, ﬁnally, whether this phosphorylation
regulates PAP activity. We found that serum stimulation
of G0 quiescent cells increases phosphorylation of PAP
and that extracellular signal-regulated kinase (ERK) is
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ﬂight (Q-TOF) mass spectrometry and the site-directed
mutagenesis studies indicated that serine 537 of PAP is the
major target site of ERK. PAP phosphorylation at serine
537 led to the increase of the nonspeciﬁc polyadenylation
activity in vitro. Therefore, our results suggest that ERK
functions as a novel regulatory kinase for PAP and that
PAP could be regulated by extracellular stimuli through
an ERK signaling pathway(s).
MATERIALS AND METHODS
DNA construction
Full length or deﬁned regions of mouse PAP were cloned
into pGEX4T-1 (Amersham) for expression as GST
fusions in Escherichia coli, and into pEBG (22) and
p3Flag (Invitrogen) for expression as GST fusions and
Flag fusions, respectively, in mammalian cells. Mutations
(S537A and S534A) were introduced into vectors by the
QuickChange site-directed mutagenesis (Stratagene) as
per the manufacturer’s instructions.
Cellculture andtransfection
HeLa cells were cultured in DMEM (Dulbecco’s modiﬁed
Eagle’s medium, Invitrogen) supplemented with 10% fetal
bovine serum (FBS) and antibiotics (penicillin 100U/ml,
streptomycin 100mg/ml and amphotericin B 0.25mg/ml).
Mammalian expression vectors (1mg for 35mm plates and
5mg for 100mm plates) were transfected by Lipofectamine
(Invitrogen) as per the manufacturer’s instructions.
Preparation ofrecombinant PAP derivatives
GST-PAP or Flag-PAP constructs or their truncation
derivatives were expressed in HeLa cells by transfection of
mammalian expression vectors. Cell lysates were harvested
from cells after wash with cold phosphate-buﬀered saline
(PBS, pH 7.2) by scrapping with 300ml of EBC solution
containing 50mM Tris–HCl, pH 7.5, 120mM NaCl, 0.5%
Nonidet P-40, 50mM NaF, 200mM sodium ortho-
vanadate, 1mM phenylmethylsulfonyl ﬂuoride and
protease inhibitor (Complete
TM; Roche). Cell lysates
were incubated at 48C for 1h with 20ml of glutathione
aﬃnity Sepharose (50% slurry, Amersham Pharmacia
Biotech) for GST-PAP. Recombinant protein G agarose
(Invitrogen) and 500ng of anti-Flag antibody were
incubated with lysates for Flag-PAP, respectively and
PAP-bound beads were extensively washed with EBC
solution.
Recombinant GST-PAP truncation constructs were
expressed in E. coli and puriﬁed using glutathione-
Sepharose. Protein synthesis in E. coli cells containing
the GST-PAP constructs was induced by adding isopropyl
b-D-thiogalactoside (IPTG) at 0.1mM and the cells were
further grown for 5h at 238C. After harvesting the cells,
the cell pellet was suspended in PBS buﬀer and sonicated.
Soluble fraction was incubated with glutathione aﬃnity
Sepharose. After repeated washes, proteins were eluted
from beads with elution buﬀer (10mM reduced glu-
tathione in 50mM Tris–HCl, pH 8.0).
Antibodies and chemicals
Antiserum to phosphoserine 537 of PAP was generated by
Peptron. Antibodies speciﬁc for PAP (Santa Cruz), GST
(Santa Cruz), ERK (Santa Cruz), phospho-ERK (Santa
Cruz), phospho-serine (Chemicon) and Flag (Sigma) were
purchased. Phorbol-12-myristate-13-acetate (PMA) and
PD98059 were purchased from Calbiochem. The recom-
binant protein kinases (Raf, MEK and ERK) were
purchased from Upstate Biotechnology.
Analysis ofPAP phosphorylation
For in vitro analysis, PAP-bound beads or 200ng of
puriﬁed proteins were phosphorylated using 2ng/mlo f
ERK, 0.1 unit of Raf or 0.1 unit of mitogen-activated
protein kinase kinase (MEK) with 10mM ATP or 0.5mlo f
[g-
32P]ATP (3000mCi/mmol) at 378C for 1h in Assay
Dilution Buﬀer (Upstate biotechnology) containing
20mM 3-(N-morpholino) propanesulfonic acid (MOPS),
pH 7.2, 25mM b-glycerophosphate, 5mM ethylene glycol
tetraacetic acid (EGTA), 1mM sodium orthovanadate
and 1mM dithiothretol. The phosphorylated products
were separated by SDS-PAGE for analysis of phosphor-
ylation or washed by EBC for further use.
For analysis of the phosphorylation status of PAP
in vivo, HeLa cells transfected with PAP constructs were
synchronized at G0, by incubating them in serum-free
medium for 12h. Quiescent cells were serum-stimulated by
changing the media to DMEM containing 20% FBS.
Alternatively, unsynchronized cells, cells were harvested
12h after transfection and PMA was added to media at
100ng/ml for activating ERK. In both cases, the cell
lysates were resolved on a 10% SDS-polyacrylamide gel
and subject to immunoblot analysis. For the quantitation
of the amounts of GST-PAP or Flag-PAP proteins, the
cell lysates were treated with -protein phosphatase (NEB,
1000 unit/ml) before gel electrophoresis.
Q-TOF analysis
For Q-TOF analysis, the GST-PAP truncation derivatives
puriﬁed from E. coli were phosphorylated in 10mM ATP
with ERK (2ng/ml) and separated by SDS-PAGE. The
band corresponding to the phosphorylated form was
excised from the gel and analyzed by nano-ESI on a
Q-TOF2 mass spectrometer (Micromass).
In vitro polyadenylation assay
Flag-PAP-bound beads were phosphorylated by ERK, as
described earlier. Brieﬂy, the lysates were treated with
-protein phosphatase (1000U/ml) in the presence of
2mM MnCl2 (ﬁnal concentration) at 308C for 1h before
binding to protein G agarose beads to create phosphate-
free protein. When necessary, PAP was phosphorylated by
ERK, as described earlier. We determined the activity of
Flag-PAP by measuring incorporation of AMP from
[a-
32P] ATP into 120nt-length RNA in the presence of
MnCl2, as described previously (28). The DNA template
for the 120nt RNA was obtained by PCR from cDNA for
prothrombin 30 untranslated region with a pair of primers
50PT and 30PT: 50PT, 50-CGA ATT CGG GCC ACT CAT
804 Nucleic Acids Research, 2008, Vol. 36, No. 3ATT CTG; 30PT, 50-GGG TAC CGC TGA GAG TCA
CTT TTA TTG G. The PCR product was cloned to the
BamHI/SmaI site of pGEM3zf (Promega). The resulting
recombinant DNA was linearized with FokI and used
for in vitro transcription by T7 RNA polymerase.
Polyadenylation reaction products were extracted with
phenol extraction and precipitated by ethanol. The
precipitates were dissolved in water and spotted in a PEI
thin layer chromatography (TLC) plate. The residual free
[a-
32P]ATP was separated from RNA by TLC with 1.5M
KH2PO4 buﬀer and the [a-
32P]AMP-incorporated RNA
were analyzed by scintillation. Alternatively, the products
were analyzed on a 5% polyacrylamide gel containing 8M
urea. We also assayed the activity of Flag-PAP in the
presence of MgCl2 instead of MnCl2 with the RNA
substrate containing a SV40 late mRNA poly(A) signal, as
described previously (29)
RESULTS
Phosphorylation of CTD of PAPwas increased by serum
induction
We examined the phosphorylation status of PAP in
response to growth stimuli using HeLa cells expressing
the CTD of PAP fused to a GST tag (GST–CTD).
Addition of serum to the quiescent HeLa cells, which were
prepared by serum starvation for 12h, increased phos-
phorylation of GST–CTD as indicated by western blotting
with phosphoserine-speciﬁc antibody (Figure 1).
Phosphorylation of CTD reached a maximum 10min
after the stimulation. We thought it unlikely that Cdks
participated in this phosphorylation because they are
known to be activated several hours after serum stimula-
tion; Cdk4 and Cdk6 are activated in mid-G1 and Cdk2
is activated in late-G1 (30). Therefore, we tested whether
a mitogen-activated protein kinase (MAPK) pathway is
involved in PAP phosphorylation. The phosphorylation
induced by serum stimulation was blocked by PD98059,
a MAPK pathway inhibitor (Figure 1), suggesting that
MAPKs participate in PAP phosphorylation.
ERK phosphorylatedserine 537 ofPAP in vitro
To identify the MAPK responsible for phosphorylation of
PAP, we attempted to phosphorylate PAP using puriﬁed
MAPKs Raf, MEK and ERK in vitro. Of these three, only
ERK, phosphorylated PAP (Figure 2A), deﬁning PAP
as a substrate for ERK kinase. To locate the ERK
phosphorylation site in PAP, we expressed truncated
derivatives of PAP as GST-fusions in HeLa cells and
puriﬁed them with glutathione resin. The resin-bound
GST fusions were phosphorylated by ERK in vitro using
[g-
32P]ATP. Phosphorylated signals were observed with all
PAP fragments containing residues 488–542, but not with
the 488–520 fragments (Figure 2B). An additional
phosphorylated band running at a similar size to CTD
corresponded to auto-phosphorylated ERK, whose gel
mobility relative to that of CTD was observed to be
slightly changed by minor perturbations of the electro-
phoresis condition, such as gel percentage and tempera-
tures. We also puriﬁed the 488–520, 488–543 and 543–595
fragments from E. coli as GST fusion forms and used
them for ERK phosphorylation (Figure 2C). The 488–542
fragment was phosphorylated, but the 488–520 and
543–595 were not. All these data allowed us to infer that
the phosphorylation site is located in residues 521–542
(Figure 2D). The 521–542 region contains eight serines
and one threonine. However, the well-known ERK
substrate recognition site of PXS/P (X; a neutral or
basic amino acid) is not present (31).
To identify the ERK phosphorylation site, we designed
an experiment using Q-TOF mass spectrometry. We
expressed and puriﬁed the CTD of PAP, which consists
of residues 488–739, from E. coli, and phosphorylated it
in vitro with ERK. Phosphorylated CTD was analyzed by
Q-TOF ESI-MS analysis. Mascot analysis (32) of the
Q-TOF ESI-MS data (Table 1) showed that the phos-
phorylation increased the molecular weight of the 515–543
peptides by 80Da, which corresponds to a single
phosphate group. Except that the 515–543 peptide, no
additional phosphorylated peptides were deduced from
Mascot analysis. These data indicate that ERK phosphor-
ylates a single site in the 515–543 region. Furthermore,
phosphorylated CTD and unphosphorylated control CTD
were analyzed by Q-TOF MS/MS analysis and the peaks
were compared. We observed peaks corresponding to
fragments containing phosphorylated serine 537 in the
phosphorylated sample (Figure 3A). Serine 537 was
previously reported as a potential nonconsensus cdk site
(24). To conﬁrm ERK phosphorylation of serine 537, we
mutated it to alanine and examined phosphorylation of
the mutant CTD fragment. The S537A mutant CTD was
not phosphorylated by ERK, while control S534A CTD in
which serine 534 had been converted to alanine was
phosphorylated (Figure 3B). We conclude that serine 537
of PAP is a unique phosphorylation site for ERK.
Figure 1. Phosphorylation of after serum stimulation. Phosphorylation
of the CTD of PAP fused to GST (GST–CTD) in transiently
transfected HeLa cells was analyzed by immunoblot using anti-
phosphoserine antibody after the cell lysates were GST pull-downed.
Cells transfected with GST–CTD were cultured in serum free media for
12h and then stimulated with 20% serum (lanes 1–3) or 20% serum
containing 50mM PD98059 (lanes 4–6) for the indicated time (lanes 1
and 4, 0min; lanes 2 and 5, 5min; lanes 3 and 6, 10min). The amounts
of GST–CTD present in the lysates were evaluated by immunoblot
using anti-GST antibody after the treatment with  protein phospha-
tase to convert multiple bands of GST–CTD to a single band.
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537of PAP
To examine the phosphorylation status of serine 537 of
PAP in vivo, we used a phosphorylated peptide corre-
sponding to the region of PAP around serine 537
(SMSVPpSPTSAT) to generate anti-phosphoserine 537
speciﬁc antibody. The peptide, encoded in exon 17, is
shared by PAP II, PAP I and other isoforms (Figure 4A),
and is well conserved in PAP from various vertebrates
(Figure 4B). To conﬁrm the speciﬁcity of the antibody, we
expressed and puriﬁed the 488–543 region of PAP fused to
GST and a S537A mutant derivative from E. coli and
treated them with ERK in vitro. Then they were analyzed
by western blot using the phospho-speciﬁc antibody.
The ERK-treated 488–542 substrate was recognized by
the phosphoserine antibody, but the untreated 488–542
substrate and the ERK-treated S537A mutant were not
(Figure 4C). These results demonstrate the speciﬁcity of
Figure 2. Phosphorylation of PAP by ERK in vitro. Lysates of HeLa cells transfected with (A) full-length GST-PAP or (B) GST-PAP truncation
derivatives were incubated with glutathione-Sepharose beads. Glutathione beads were phosphorylated by constitutively active kinases in the presence
of [g-
32P]ATP for 1h at 378C. Sample buﬀer was added to stop the reaction and proteins were separated by SDS-PAGE. Phosphorylated bands were
visualized by autoradiography. Expression of PAP derivatives were conﬁrmed by immunoblot on the lysates with GST antibody. (C) GST fusion
derivatives were expressed in E. coli. Fusion proteins were eluted from glutathione-Sepharose beads and each proteins were phosphorylated by
constitutively active ERK in the presence of [g-
32P]ATP for 1h at 378C. The products were analyzed as in (B) and input proteins were also visualized
by Coomassie staining. (D) Data of (B) and (C) are schematically presented to show the region of PAP required for the phosphorylation by ERK.
806 Nucleic Acids Research, 2008, Vol. 36, No. 3the antibody and provide another line of evidence that
serine 537 of PAP is phosphorylated by ERK.
ERK phosphorylates serine 537 ofPAP in vivo
To determine whether ERK phosphorylates PAP in vivo at
serine 537, we stimulated ERK activity in HeLa cells and
assessed PAP phosphorylation. We tested whether PAP
was phosphorylated at serine 537 when the growth of the
quiescent HeLa cells was stimulated by the addition
of serum. GST–CTD was ﬁrst examined for phosphoryla-
tion using the anti-phosphoserine 537 speciﬁc antibody
(Figure 5A). The phosphorylation signals were quantiﬁed
against the amount of GST-CTD. Phosphorylation at
serine 537 peaked at 10min with the concomitant increase
of the phosphorylated forms of ERK after the serum
addition, but the co-treatment with PD98059 inhibited the
phosphorylation. Next, we further tested whether that
full-length PAP is phosphorylated by ERK using
GST-PAP (Figure 5B). HeLa cells transfected with the
GST-PAP construct were treated with phorbol-12-
myristate-13-acetate (PMA), a stimulatory agonist,
which activates ERK. Phosphorylation of GST-PAP was
examined with anti-phosphoserine 537 speciﬁc antibody.
We observed that the PMA treatment increased the
phosphorylation and that the increase was correlated
with the activation of ERK. In addition, the co-treatment
with PD98059 reduced the PMA eﬀect on phosphoryla-
tion. However, PD98059 did not entirely inhibit phos-
phorylation at serine 537. It remains to be demonstrated
whether this incomplete inhibition was due to the residual
activity of ERK even in the presence of PD98059 or it
reﬂects the presence of another kinase that can phosphor-
ylate serine 537 of PAP.
We also investigated whether endogenous PAP is
phosphorylated at serine 537 by ERK. HeLa cell lysates
were prepared after the PMA stimulation, immunopreci-
pitated with anti-phosphoserine 537 antibody and the
immunoprecipitates were immunoblotted with anti-PAP
antibody. When this co-immunoprecipitation experiment
was employed with cells treated with PMA for 10min, a
106kD protein band (33) appeared in the immnoprecipi-
tates by anti-phosphoserine 537 anitbody, but not by
preimmune antiserum (Figure 6A), Therefore, we con-
clude that this band is the phosphorylated PAP at serine
537. The 106kD band signal increased and reached to the
maximum in 10min after the PMA addition, but its signal
was not increased by the co-treatment with PD98059
(Figure 6B). Taken together, our data suggest that ERK
phosphorylates serine 537 of PAP in vivo. A 100kD band
was detected with pre-immune serum in lane 3 of
Figure 6A. Although we did not further examine its
identity, we conclude that this band is not related to
phosphorylation of serine 537 because it was not observed
with anti-phosphoserine 537 antibody.
Effectof phosphorylation at serine537 on PAP activity
To examine eﬀects of phosphorylation of PAP at serine
537, we measured the nonspeciﬁc polyadenylation activity
of PAP in a Mn
2+-containing reaction buﬀer (28).
Flag-PAP was prepared from HeLa cell lysates by
immobilization using anti-Flag antibody and protein G
beads. It is likely that Flag-PAP puriﬁed from unsyn-
chronized cells is partially phosphorylated. This partial
phosphorylation might make it diﬃcult to evaluate the
eﬀect of ERK on in vitro PAP activity. We treated the
HeLa cell lysates with protein phosphatase prior to
the puriﬁcation of Flag-PAP and then treating with
ERK. The polyadenylation activity of the puriﬁed Flag-
PAP was assayed before and after ERK treatment and
reaction products were analyzed by gel electrophoresis
Table 1. Mascot search result of phosphorylated PAP-CTD
a
Query Observed
b Mr(expt)
c Mr(calc)
d Delta
e Miss
f Score
g Expect
h Rank
i
1 1005.52 3013.52 3013.36 0.17 0 44 0.58 1
2 1010.85 3029.51 3029.35 0.16 0 66 0.0034 1
3 1032.21 3093.59 3093.32 0.27 0 17 2.8e+02 1
4 1032.51 3094.49 3093.32 1.17 0 26 36 1
5 1037.51 3109.49 3109.32 0.18 0 39 2.1 1
Query Peptide
j
1 LTALNDSSLDLSMDSDNSMSVPSPTSAMK
2 LTALNDSSLDLSMDSDNSMSVPSPTSAMK+Oxidation (M)
3 LTALNDSSLDLSMDSDNSMSVPSPTSAMK+Phospho (ST)
4 LTALNDSSLDLSMDSDNSMSVPSPTSAMK+Phospho (ST)
5 LTALNDSSLDLSMDSDNSMSVPSPTSAMK+Oxidation (M); Phospho (ST)
aThe C-terminal domain from 488 to 739 of PAP was overexpressed in E. coli and puriﬁed. The puriﬁed CTD was phosphorylated by ERK in vitro.
Untreated and phosphorylated CTD were compared by Q-TOF Electrospray Ionization Mass Spectrometry (ESI/MS). Fragment ion spectra
generated from ESI/MS were analyzed using MASCOT tools.
bExperimental m/z value.
cTransformed relative molecular mass from experimental m/z.
dCalculated relative molecular mass of the matched peptide.
eDiﬀerence between the experimental and calculated masses.
fNumber of missed trypsin cleavage sites.
gIons score.
hExpectation value for the peptide match.
iRank of the ions match (1–10, where 1 is the best match).
jMatched peptide.
Nucleic Acids Research,2008, Vol. 36,No. 3 807and thin layer chromatography (Figure 7). The activity
of Flag-PAP increased by about 40% with the ERK
treatment, while that of the S537A mutant was unaﬀected,
suggesting that phosphorylation of PAP at serine 537A by
ERK increased its poly(A) addition activity. These results
indicate that PAP activity is increased by single-site
phosphorylation at serine 537 by ERK.
Since the PMA treatment causes phosphorylation of
PAP at serine 537 in the cell, we also used GST-PAP
puriﬁed from the PMA-treated cells for the in vitro
phosphorylation assay. We found that the PAP activity
increased with the PMA induction, but that of the S537A
mutant did not (Figure 8A). Furthermore, the increase of
the PAP activity by the PMA induction disappeared when
treated concomitantly with an ERK inhibitor, PD98059
(Figure 8B). These results further support that phosphor-
ylation of PAP at serine 537 increases its activity.
We also carried out the polyadenylation assays in
the presence of MgCl2 using a substrate carrying the
polyadenylation signals. However, we did not observe the
speciﬁc polyadenylation products (data not shown),
possible due to lack of other 30 processing factors in the
puriﬁed Flag-PAP or GST-PAP.
DISCUSSION
In this study, we show that PAP is phosphorylated at a
serine 537 in response to extracellular growth stimuli.
Since the PAP phosphorylation increases its poly(A)
addition activity in vitro, we conclude that PAP is
Figure 3. Analysis of phosphorylation site. (A) MS/MS spectrum of the doubly charged ion of the peptide including S537. CTD of PAP (residues
488–739) was overexpressed in E. coli and puriﬁed. The puriﬁed CTD was phosphorylated by ERK using 10mM ATP in vitro. The untreated
(control) and phosphorylated CTD forms were excised from gel and compared by Q-TOF MS/MS analysis. The sequence annotations above the
spectra correspond to the y-ion fragment series. The sequences (C- to N-terminus) within the spectrum correspond to the signals indicated by the
vertical lines. (B) The wild-type GST-CTD (lane 1) and mutants S537A (lane 2) and S534A (lane 3) were expressed in E. coli and puriﬁed.
The puriﬁed GST–CTD proteins were phosphorylated by ERK in vitro using [g-
32P]ATP. Phosphorylated band were visualized by autoradiography
after SDS-PAGE. Input proteins (200ng) were also visualized by Coomassie staining.
808 Nucleic Acids Research, 2008, Vol. 36, No. 3regulated through an ERK-dependent signaling pathway.
However, we do not exclude the possibility that PAP
phosphorylation at serine 537 diﬀerently aﬀects speciﬁc
polyadenylation in vivo because phosphorylation may
participate in modulation of interaction between PAP
and other factors involved in 30 processing of mRNA.
Since poly(A) tails are implicated in maintaining mRNA
stability, exporting mRNA from nucleus to cytoplasm,
and enhancing translation eﬃciency (13,14), regulation of
PAP could be an important mechanism by which cells can
alter gene expression.
Our ﬁnding that PAP activity can be regulated by
phosphorylation through an ERK-dependent pathway
supports the hypothesis that PAP activity responds to
extracellular growth stimuli because ERK is a member of
the MAPK family of kinases (34). Upon mitogenic growth
factor activation, ERK promotes both the proliferation of
quiescent cells in G0 and the progression of cell cycling
through the restriction point in G1 phase (35). Our results
show that the increase of phosphorylation at serine 537
occurs in about 10min after serum induction, which
coincides with the timing of ERK activation, implying
that PAP activity is activated during cell proliferation
upon serum induction, which coincides with the timing of
ERK activation, implying that PAP activity is activated
during cell proliferation upon serum induction. In
addition to its important role in the proliferation of
quiescent cells, ERK is involved in a various cellular
functions including apoptosis, proliferation and diﬀeren-
tiation (36,37). Furthermore, ERK participates in regulat-
ing the somatic cell cycle in G2 and M phase (38) and
Figure 5. Phosphorylation of serine 537 by stimulation of ERK in vivo.
(A) HeLa cells were transfected with GST–CTD (residues 472–739)
(lanes 1–6) and its S537 mutant (lanes 7–9). Cells were cultured in
serum free media for 12h and then stimulated with 20% serum (lanes
1–3 and 7–9) or 20% serum containing PD98059 (50mM) (lanes 4–6)
for the indicated time (lanes 1, 4 and 7, 0min; lanes 2, 5 and 8, 5min;
lanes 3, 6 and 9, 10min). To examine the phosphorylation status of
serine 537, GST pull-downed complexes were visualized by immunoblot
with anti-phosphoserine 537 antiserum. Activation of ERK in total
lysates was conﬁrmed by immunoblot with anti-p-ERK antibody. The
phosphorylation signals were quantiﬁed against the amount of GST-
CTD treated with  protein phosphatase, and shown below the the
immnoblots. (B) HeLa cells were transfected with full-length GST-PAP.
PMA alone (lanes 1–3) or with PD98059 (50mM) (lanes 4–6) was added
to 100ng/ml at 12h after transfection and the cells were further
incubated (lanes 1 and 4, 0min; lanes 2 and 5, 5min; lanes 3 and 6,
10min). GST pull-downed complexes from the cell lysates were
visualized by immunoblot with anti-phosphoserine 537 antiserum.
The amounts of GST-CTD present in the lysates were evaluated with
anti-GST antibody after the treatment with  protein phosphatase.
Figure 4. Generation of anti-phosphoserine 537 antibody. (A) The
position of serine 537 is shown in exons of PAP. PAP I and PAP II
share the region exons 1–19. (B) Amino acid sequences near 537 serine
are conserved in vertebrate PAPs. The sequences of frog, cow, human,
chicken and mouse PAP were shown aligned. The best alignments for
PAP paralogs, PAPb and PAPg were also shown. (C) Antisera against
the phosphospeciﬁc-peptide corresponding to 10 amino acids around
serine 537 was generated from rat. The GST-488-542 PAP derivative
(lanes 1, 2, 5 and 6) and mutant S537A (lanes 3, 4, 7 and 8) were
puriﬁed from E. coli and phosphorylated by ERK in vitro using 10mM
ATP. Odd-numbered lanes, ERK-treated; even-numbered lanes,
no ERK-treated. The products were analyzed by immunoblot with
anti-phosphoserine 537 (lanes 1–4) or pre-immune serum for control
(lanes 5–8).
Nucleic Acids Research,2008, Vol. 36,No. 3 809is also activated in Xenopus oocyte maturation (39).
Therefore, PAP regulation by ERK could be used as a
general means to modulate gene expression by varying
poly(A) mRNA tail length during those varied and critical
cellular events.
Phosphorylation of PAP at serine 537 by ERK had
not been predicted previously, because serine 537 is one
of several PAP nonconsensus cdk sites, which can be
phosphorylated p34cdc/cyclin B. Furthermore, PAP has
no apparent ERK recognition site (PXS/P, where X is a
neutral or basic amino acid) (31) or ERK docking site
(DEF: docking site for ERK, FxFP) (40). Serine or
threonine followed by a proline (S/TP) was suggested as
the minimal consensus sequence for ERK (41,42). In the
case of PAP, in fact, serine 537 is followed by proline,
but it still remains obscure how ERK recognizes PAP.
The kinase interaction motif (KIM) of ERK serves as a
common docking domain for interactions with other
proteins such as activators, regulators and substrates (43).
Interaction between positively charged amino acid clusters
of substrates and aspartic acid in the KIM site of ERK is
known to be required for recognition (44). There is a
cluster of positively charged residues (bold and under-
lined) near the serine 537 residue, 489 KR KQLHQ
LLPSHV LQKRK KKHST 500. It is possible that ERK
recognizes PAP through an interaction between KIM and
positively charged amino acids near the serine 537 residue.
Interestingly, PAPb, which is identiﬁed as a testis-speciﬁc
PAP (45,46), has the conserved sequences near serine 537
and the KIM site, suggesting that PAPb can be
phosphorylated by ERK at serine 537 (Figure 4). On the
other hand, PAPg, which is another PAP paralog (47),
does not show any similarity with the sequences near
serine 537 of PAP (Figure 4) or the KIM site.
It is well known that phosphorylation of a protein can
lead to a conformational change of the protein that results
in an increase or decrease in activity. Protein phosphor-
ylation is also able to change the aﬃnity of binding
proteins. There are several lines of evidence that PAP
activity is modulated by phosphorylation. In the M-phase
of the cell cycle, hyperphosphorylation of PAP by p34cdc/
cyclin B on cdk sites represses PAP activity (24), as
Figure 6. Phosphorylation of serine 537 of endogenous PAP. HeLa
cells were cultured in media with 10% serum. When cell conﬂuence
reaches 70–80%, PMA was added to 100ng/ml. At 10min after the
PMA treatment, cell extracts were prepared. They were immunopreci-
pitated with anti-phosphoserine 537 antibody (lane 2) or pre-immune
serum (lane 3). The immunoprecipitates were blotted with anti-PAP
antibody. Lysates (5% input) alone (lane 1) or anti-phosphoserine
537 antibody alone (lane 4) before the immunoprecipitation was
electrophoresed and blotted with anti-PAP antibody for controls.
(B) Alternatively, cell extracts were prepared at the indicated time
(lanes 1 and 4, 0min; lanes 2 and 5, 5min; lanes 3 and 6, 10min) after
PMA alone (lanes 1–3) or with PD98059 (50mM) (lanes 4–6) was added
to 100ng/ml. The lysates were blotted with anti-phosphoserine 537,
anti-PAP, anti-pERK or anti-ERK antibody.
Figure 7. Eﬀect of phosphorylation of serine 537 on nonspeciﬁc activity
of PAP. (A) HeLa cells were transfected with fusions of Flag-PAP wt
(lanes 2–4) or S537A (lanes 5–7) and cell lysates were treated with
-protein phosphatase. Flag-PAPs were precipitated by incubating
cell lysates with protein G agarose beads and anti-Flag antibody. Flag-
PAP-bound beads were phosphorylated with the indicated amounts of
ERK (lanes 2 and 5, 0ng/ml; lanes 3 and 6, 1ng/ml; lanes 4 and 7,
2ng/ml) in vitro and used for the in vitro polyadenylation assay. We
determined the activity of Flag-PAP by measuring incorporation of
AMP from [a-
32P] ATP into 120nt-length RNA. Polyadenylated RNAs
were analyzed on a 5% polyacrylamide gel containing 8M urea (left).
The 120nt-length RNA labeled at the 30 end with [
32P]pCp was
electrophoresed as a control (lane 1). The Flag-PAP present in the
puriﬁed fraction was semiquantitatively determined by immunoblotting
with anti-Flag. Phosphorylation of PAP at serine 537 was visualized by
immunoblot with anti-phospho-537 serine. Alternatively, polyadeny-
lated RNAs were separated from free [a-
32P] ATP in PEI membrane by
TLC and analyzed by scintillation (right). Relative PAP activities are
expressed as the quantities of polyadenylated RNAs relative to that of
RNA polyadenylated by Flag-PAP(wt) alone after normalization to
imunoblot signals of PAP. The values are calculated from three
independent experiments.
810 Nucleic Acids Research, 2008, Vol. 36, No. 3discussed in the Introduction. Recombinant PAP puriﬁed
from insect cells shows lower activity than the recombi-
nant enzyme puriﬁed from E. coli, as a feature attributed
to phosphorylation: insect recombinant enzymes have
about 5-fold higher Km-values for the substrate (48).
When molt-3 cells are infected with human immunodeﬁ-
ciency virus-1 (HIV-1), phosphorylation of PAP increases
PAP activity although the kinase responsible for the
Figure 8. Nonspeciﬁc activity of PAP isolated from HeLa cells treated with PMA. (A) Non-speciﬁc activities of PAP from HeLa cells transfected with
GST-PAP wt [lanes 1–3) or S537A (lanes 4–6)] were measured prior to and following the treatment with PMA (100ng/ml). The cells were harvested at
the indicated time (lanes 1 and 4, 0min; lanes 2 and 5, 5min; lanes 3 and 6, 10min) after the treatment with PMA (100ng/ml). GST-PAPs were
precipitated by incubating cell lysates with glutathione beads. GST-PAP-bound beads were used for the in vitro polyadenylation assay. We determined
the activity of Flag-PAP by measuring incorporation of AMP from [a-
32P] ATP into 120nt-length RNA. Polyadenylated RNAs were analyzed on
a 5% polyacrylamide gel containing 8M urea (left). The position of the 120nt-length substrate RNA is indicated by an arrow. The GST-PAP present
in the puriﬁed fraction was semiquantitatively determined by immunoblotting with anti-GST. Phosphorylation of PAP at serine 537 was visualized
by immunoblot with anti-phospho-537 serine. Alternatively, polyadenylated RNAs were separated from free [a-
32P] ATP in PEI membrane by TLC
and analyzed by scintillation (right). Relative PAP activities are calculated as in Figure 7. (B) HeLa cells were transfected with GST-PAP. The cells
were harvested at the indicated time (lanes 1 and 4, 0min; lanes 2 and 5, 5min; lanes 3 and 6, 10min) after the treatment with PMA (100ng/ml) alone
(lanes 1–3) or with PD98059 (50mM) (lanes 4–6). GST-PAPs were precipitated and used for the in vitro polyadenylation assay, as in (A).
Nucleic Acids Research,2008, Vol. 36,No. 3 811phosphorylation is unclear (49,50). Therefore, a picture
had emerged that phosphorylation of diﬀerent sites
resulted in diﬀerent eﬀects on the activity of PAP, but
the eﬀect of phosphorylation at any speciﬁc site was not
deﬁned until this work. Here, we show that single site-
phosphorylation at serine 537 is responsible for the
increase of PAP activity. Colgan et al. (24) previously
suggested that that full phosphorylation at both consensus
and nonconsensus cdk sites represses PAP activity. Since
serine 537 was previously considered a nonconsensus cdk
site, it is likely that the eﬀect of single-site phosphorylation
on PAP activity diﬀers from that of hyperphosphorylation
at the multiple sites. Phosphorylation at other noncon-
sensus or consensus cdk sites may interfere with that at
serine 537 in modulation of PAP activity.
In summary, we have shown that PAP is phosphory-
lated in response to extracellular stimuli. This phosphor-
ylation occurs by action of ERK. ERK phosphorylates
the serine 537 residue of PAP speciﬁcally and the
phosphorylation stimulates PAP activity. These data
suggest that ERK is a regulatory kinase for PAP. Given
that ERK is an important downstream component in
the MAPK cascade that serves to integrate a variety
of extracellular signals, our ﬁndings indicate that
PAP activity can be modulated through ERK signaling
pathways by extracellular signals.
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